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Abstract
Background: Sarcopenia and obesity have been independently associated with physical function decline, however
little information is currently available on the relationship between sarcopenic obesity and physical performance,
mainly in middle aged women. The present study aims to estimate the prevalence of sarcopenic obesity and to
explore the relationship between sarcopenic obesity and physical performance in middle-aged women from
Northeast Brazil.
Methods: A cross-sectional study of women (40–65 years) living in Parnamirim, a city in Northeast Brazil (n = 491).
Physical performance was assessed by grip strength, knee extensor and flexor strength (isometric dynamometry),
gait speed, and chair stands. Using bioelectrical impedance analysis (BIA), appendicular skeletal muscle mass divided
by height squared (kg / m2) was used to define sarcopenia. Waist circumference ≥ 88 cm was defined as abdominal
obesity. Sarcopenic obesity was defined as the coexistence of obesity and sarcopenia. The physical performance
outcomes were regressed in four groups defined by combinations of sarcopenia and obesity, adjusting for potential
confounders (age, education and menopausal status).
Results: Prevalence rates of the four obesity-sarcopenia groups were: Sarcopenic obesity (7.1 %), obesity (67.4 %),
sarcopenia (12.4 %) and normal (13 %). Women with sarcopenic obesity had significantly lower grip strength,
weaker knee extension and flexion and longer time to raise from a chair compared with non-obese and non-
sarcopenic women (p.values < 0.001). Except for the chair stands, these statistically significant differences were also
found between sarcopenic obese and obese women. There was no significant difference for gait speed across the
four groups (p = 0.50).
Conclusion: Sarcopenic obesity was present in 7 % of this population of middle-aged women from Northeast Brazil
and it was associated with poor physical performance. Sarcopenic obesity may occur in middle-aged women with
performance limitations beyond pure sarcopenia-related muscle mass or obesity alone.
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Background
Aging is a continuous process that involves physiological
changes in multiple body systems resulting in reduced
functional capacity [1]. The musculoskeletal system, in-
volving bodily functions such as muscle contraction,
movement and locomotion, is affected by loss of lean
mass, particularly muscle mass (sarcopenia) [1].
Progressive muscle mass loss begins around 40 years
and it is estimated that it decreases by 8 % every decade
[2, 3]. After age 70, this loss rate increases to 15 % per
decade [2, 3]. Although these changes have been found
in the aging process of both men and women, a decrease
in muscle mass does not occur at the same rate and age
for both sexes. Study has reported a rapid strength loss
in women around the age of 50, which is not observed
in men until at least the age of 60 [4]. Menopause occurs
during the same middle-aged period and it is associated
with the natural decline of estrogen directly reflected in
increasing visceral fat mass and decreasing bone density,
muscle mass and strength [4]. A higher prevalence of
obesity and a decrease in muscle mass are observed
during menopause, and these health issues are separately
related to a decline in function [5–7].
Furthermore, a higher rate of functional decline has
been reported in subjects with sarcopenic obesity (SO),
the co-existence of obesity and sarcopenia [8–10]. Lipid
infiltration in muscle tissues seems to exacerbate sarco-
penia, since accumulation of lipids both prevents incorp-
oration of amino acids and reduces protein synthesis in
the muscle [11]. For both men and women, having obes-
ity and sarcopenia together due to a possible synergic ef-
fect can further decrease physical functioning [10, 12].
However, changes in body composition, such as obesity
and sarcopenia, have been underdiagnosed; and when di-
agnosed they tend to be more frequent in older women
than men [13].
Although sarcopenia and obesity have been independ-
ently associated with physical function decline [7, 14],
little information is currently available on the relation-
ship between SO and physical performance [10, 12].
Questions remain whether the effects of obesity on
physical performance can be detected beyond those of
sarcopenia among women that are both obese and
sarcopenic. Furthermore, to our best knowledge, no
study has examined this relation using objective and
valid measures of physical performance and body com-
position in middle-aged women.
The number of obese people is increasing in Brazil
and the current prevalence of excess weight is at least 3-
times higher than that of undernutrition [15]. To illus-
trate, in two recent studies conducted in the south of
Brazil [16, 17], two thirds of middle-aged women had
abdominal obesity; however, these studies did not look
at sarcopenia.
The present study aims to estimate the prevalence of
sarcopenic obesity and to explore the relationship be-
tween sarcopenic obesity and physical performance in
middle-aged women from Northeast Brazil.
Methods
Study population/data collection
This cross-sectional study took place in Parnamirim, a
city in the Northeast of Brazil located in Natal’s metro-
politan region, the capital of Rio Grande do Norte (RN)
state. This city has around 200,000 inhabitants, distrib-
uted across 123.5 km2, and is 100 % urbanized.
In this paper, we used baseline data from an ongoing
longitudinal research [18]. The longitudinal study aims
to analyze the influence of hormone levels on sarcopenia
(muscle loss) and physical functioning. The present data
were collected between April and November of 2013.
The study population was composed of women living
in Parnamirim (40–65 years). Women were recruited by
advertisements in all primary care centers across the
city. Brazil has universal health care coverage, and all cit-
izens are entitled to register at local neighborhood
health centers. The coverage of the primary health care
is system is estimated to be 74.5 % in Parnamirim [19].
A convenience sample of five hundred women com-
prised the baseline study sample. To be eligible to par-
ticipate in the study, women had to have at least one
ovary, with no pituitary or thyroid alterations, without
serious neurological diseases that could prevent them
from responding to questions, and be free of painful
conditions that could compromise the measurement of
physical performance outcomes. Women who refused to
complete all data collection stages were excluded. Our
final sample consisted of 491 women.
All women were evaluated in a single community
health center of Parnamirim, RN. The assessments were
conducted by trained interviewers using standard
protocols.
Ethics
All participants were informed of the objectives and pro-
cedures of the research at first contact and signed an in-
formed consent form. The study protocol received
approval from the Ethics and Research Committee of




Physical performance was assessed by five tests: grip
strength, knee extension and flexion strength, gait speed
and chair stands. These constituted the dependent vari-
ables for this study. Grip strength: the dominant hand
was evaluated with a Jamar® dynamometer in the second
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handle position [20]. The participant was positioned, as
recommended by the American Society of Hand Thera-
pists [21], seated with shoulder fully adducted and neu-
trally rotated, elbow flexed at 90° and forearm in a
neutral position. The participants were requested to
squeeze the dynamometer with maximal isometric effort
without any other body movement, for five seconds. The
test was performed three times, with a one-minute inter-
val between measurements. The mean of these three tri-
als was used for analysis.
Knee flexion and extension strength (dominant
limb) were measured with the Hoggan® portable dyna-
mometer, MicroFET2® model (isometric dynamom-
eter). The evaluation of extensors was performed with
the subject positioned in the prone position on a
stretcher, with the knee flexed at 90° and the thigh
fixed to the stretcher by an inelastic band. The dyna-
mometer was fixed on the anterior surface of the
lower limb, on the line immediately proximal to the
malleolus. The evaluation of flexors was carried out
in the same position, however with the extended knee
and the dynamometer positioned on the posterior
surface of the lower limb, immediately above the line
of the malleolus. Three maximal isometric contrac-
tions of five seconds were requested with one-minute
intervals between measurements. The arithmetic mean
of the three measurements in kilograms/force (kgf )
was considered for analysis [22].
For gait speed, a 4-m walk at the subject’s usual pace
was timed. The faster of two walks was used. Gait speed
was calculated in meters per second [23, 24].
For the chair stand test, participants were asked to
stand up and sit down five times as quickly as possible
with arms folded across their chests and were timed in
seconds from the initial sitting position to the fifth
standing position [23, 24].
Classification of obesity, sarcopenia and sarcopenic obesity
Women with a waist circumference ≥ 88 cm were con-
sidered obese, as proposed by Brazilian obesity guide-
lines [25]. Janssen et al. [26] have described their results
suggesting that waist circumference is a better marker of
health risk than BMI, and consequently a greater em-
phasis should be placed on waist circumference in the
obesity classification system. Waist circumference may
provide an estimate of increased abdominal fat even in
the absence of a change in BMI, avoiding some mis-
classification [26]. Waist circumference (cm) was mea-
sured using a “fiber glass” metric tape (divisions of
1 mm) and the measurement point was the mid-way
point between the lowest rib and the iliac crests while
the subject was standing at the end of normal expiration
[27]. Participants were positioned with their feet
together, arms crossed over their chest and instructed to
relax.
All participants underwent body composition analysis
using the same InBody R20 bioelectrical impedance ana-
lysis (BIA) machine in compliance with the manufac-
turer’s instructions. This BIA model is composed of
eight electrodes, two for each hand and two for each
foot, and performs analysis in 20 and 100 KHz with a
current of 250 μA. The body composition was automat-
ically calculated according to predictive equations pro-
vided by the manufacturer. The skeletal muscle mass
index (SMI) was assessed considering SMI = ASM (sum
of appendicular skeletal muscle mass) (kg) / height2 (m).
BIA presents good correlation with predictions made by
magnetic resonance imaging [28] and Dual-energy X-ray
absorptiometry-DEXA [29]. Although it is not the gold
standard, it is used in research [30–32], it is a reliable al-
ternative for evaluation of body composition, and it has
advantages of being portable, lower cost and not expos-
ing subjects to radiation.
Using the skeletal muscle mass index (SMI) measured
by bioelectrical impedance, women were classified as
sarcopenic if they had SMI values below the 20th per-
centile of the sample studied (<6.08 kg / m2) [33, 34].
SO was defined as the coexistence of obesity and sarco-
penia [8, 9]. Next, the women were classified into four
groups: Obese, sarcopenic, sarcopenic obese, and lastly,
non-sarcopenic non-obese women, herein called normal
women.
Covariates Age, sex, marital status, education, income,
physical activity and menopausal status were identified
as potential confounders of the association between
obesity, sarcopenia and physical function, according to
the literature on risk factors for physical performance
[18, 35, 36].
Demographic and socioeconomic variables Age was
evaluated in years. Education was assessed as years of
schooling and then categorized into three groups: less
than basic education (up to seven years), between basic
and secondary (more than seven and less than eleven
years), and secondary or more (eleven years and over).
Marital status was classified according to the self-
reported presence or absence of a common law union.
The race/ethnic group was also declared by the partici-
pant as white, black or mixed race (pardo).
Family income was categorized according to the
Brazilian minimum monthly wage (MW), which is the
lowest remuneration that employers may legally pay
workers. Theoretically, this MW should be enough to
supply the normal needs of food, housing, clothing,
hygiene and transport for a family. At the time of the
interview, the MW was R$678.00 (Brazilian Real) per
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month (approximately $250US dollars/month). How-
ever, according to the Statistics and Socioeconomic
Studies Department of Brazil (DIEESE) [37], this
minimum salary is insufficient. In our study, family
income was dichotomized as less than 3 MW and
3 MW or more (3 MW is R$2.034 Brazilian Real,
which is equivalent to US$750 dollars). The choice of
3 MW was based on what is considered to be the
poverty threshold in the Northeastern region of Brazil
[18].
Physical activity Women were asked if they regularly
practiced physical activity. In the event of an affirmative
answer, they were asked further about frequency,
duration and type of physical activity. To register seden-
tary activity, women were asked to report how many
hours they remained seated in a regular day. This vari-
able was dichotomized into 4 h/day or less and more
than 4 h/day [38]. For walking behavior, women were
instructed to report how many days per week, and for
how long per day they had walked for more than 10 min
without stopping during the last week. A walking indica-
tor was constructed to distinguish women walking
90 min/week or more [18].
Menopausal status Menopausal status was defined
using the classification STRAW (Stages of Reproductive
Aging Workshop classification) [39] or a self-report of
hysterectomy. Women were classified into five groups:
premenopausal (regular menses), perimenopausal (ir-
regular menses, with differences in cycle length over
seven days or amenorrhea up to one year), postmeno-
pausal (absence of menses for over one year), hysterec-
tomy carried out before 40 years old or after age 40.
Body mass index, hip-waist ratio and skeletal muscle
mass index Weight (kg) was measured by the Wiso®
W903 digital scale and height (m) by a stadiometer. To
measure hip circumference (cm), a fiber glass® metric
tape was used and the hip measurement was the largest
horizontal circumference around the hips. Waist-hip ra-
tio was calculated by dividing these variables (waist/hip)
[27]. Body mass index (BMI) was calculated by dividing
body weight by height squared (kg/m2). The skeletal
muscle mass index (SMI) was assessed considering SMI
= ASM (sum of appendicular skeletal muscle mass) (kg)
/ height2 (m) [33], by an InBody R20 BIA machine.
Data analysis
We started the data analysis with a descriptive analysis
of the sample. Means and standard deviations of quanti-
tative variable frequencies of categorical variables were
estimated. We utilized Analysis of Variance (ANOVA)
methods to compare the mean of physical performance
measures across the four normal, obese, sarcopenic and
sarcopenic obese groups. We used the Kolmogorov-
Smirnov test to evaluate the normality of the data. The
post-hoc multiple comparisons Bonferroni test was used
to verify which of these four groups were significantly
different from each other. Finally, we constructed
multivariate linear regression models to estimate the
mean of physical performance measures in each of the
four groups, adjusting for potential confounders. The
potential confounders were identified according to the
literature and bivariate analyses (p < 0.20) of their rela-
tionships with physical performance measures. All ana-
lyses were conducted using SPSS version 20.0 (SPSS,
Chicago, IL, USA).
Results
The total sample characteristics are shown in Table 1.
The sample consisted of 491 women with a mean age of
49.95 ± 5.56 years. Approximately 70 % were married or
living in common law unions and 55 % were of mixed
ethnic groups. Nearly 41 % had less than primary educa-
tion, and 70 % were living below the poverty threshold
of 3 MW. Almost 75 % reported no regular physical
activity.
Table 2 shows the sample distributions for categorical
variables by groups of obese women (67.4 %), normal
(13 %), sarcopenic (12.4 %) and sarcopenic obese (7.1 %).
No significant differences between the four groups were
found according to socioeconomic status or health be-
haviors. SO was more prevalent among the women who
had had a hysterectomy and among the premenopausal
women than among peri and post-menopausal women
(p < 0.05).
In multiple comparisons using Bonferroni correction,
all differences in body distribution variables across the
four groups were significant, except differences in BMI
between normal women (25.18 ± 2.06) and sarcopenic
obese (26.23 ± 2.68) (p = 0.98); in waist/hip between
obesity and SO (p = 1.00); and in skeletal muscle mass
between sarcopenia and SO (p = 1.00) (Table 3).
Table 4 summarizes the results of adjusted and un-
adjusted analyses of the physical performance variables
across the groups. Age, education and menopausal status
were considered potential confounders according to the
literature and the bivariate analyses, since they were as-
sociated with obesity/sarcopenia groups (p < 0.20). There
were significant differences between groups in strength
(grip strength, knee flexor and extensor strength) and
timed chair stands: women classified as sarcopenic obese
had the worst physical performance, with lowest mean
values for strength variables and the longest time for the
timed chair stands. Average gait speed was not different
across groups (p = 0.50).
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Multiple comparisons showed that in general, women
with sarcopenia had significantly worse performance
than obese women (grip strength p < 0.001; knee flexor
strength p < 0.003; knee extensor strength p < 0.001). SO
women showed lower mean values than obese women in
all strength variables (p < 0.001) (Table 4). It also appears
that obesity and sarcopenia impose a synergic ill effect
on physical performance. It is best demonstrated when
we look at differences in times for chair stands. For sar-
copenic obese women, it took an average of 1.18 (that is,
10.89–9.71) seconds longer than normal women to
stand, which is more than what would be expected by
adding the 0.40 (that is, 10.11–9.71) excess time of obese
women compared to normal women, and 0.05 (that is,




Sarcopenic obesity (SO) was relatively frequent and as-
sociated with poor physical performance in middle-aged
women from Northeast Brazil. Women with SO had sig-
nificantly lower grip strength and knee extension and
flexion strength when compared with normal and obese
women. Although not statistically significant, women
with SO tended to have lower values in the three muscle
strength indicators (grip strength, knee extension and
flexion strength), compared with sarcopenic non-obese
women. Concerning chair stands, sarcopenic obese
women did not differ from obese women, but it took
them longer to raise from a chair than non-obese
women with or without sarcopenia.
Prevalence findings
The prevalence of SO in our study was 7.1 %. Due to
the lack of a standard definition for SO, it is difficult
to compare its prevalence across populations. In
addition, in the eyes of clinicians and researchers, SO
is more a problem for older women and has seldom
been studied in middle-aged women. The few existing
studies report wide-ranging results. A Korean study
found that the prevalence of SO varies from 0.8 to
11.8 % in women between 40 and 59 years, according
to different indices of definition [40]. Among older
women, the prevalence of SO has been as high as
19.2 % in Taiwanese women (mean age: 63.3 years)
[41] and 21.5 % in Brazilian women (mean age:
67.2 years) [42]. Furthermore, the prevalence rate of
SO in Canadian women aged 68–82 years old was
10.8 % [43], close to the prevalence of 9.2 % in post-
menopausal European women (mean age 57.4 years)
[44]. The muscle mass can be influenced by age,
height, body weight and ethnicity, but also by nutri-
tion and life course exposure to social and economic
adversity [45, 46]. Ethnicity and social and economic
life course adversity are often difficult to separate. As
an illustration, elderly Mexicans have less muscle and
Table 1 Characteristics of the total sample
Variables (n = 491) n % or mean ± SD
Age 491 49.95 ± 5.56
Education
Primary education 205 41.8
Between primary and secondary 204 41.5
Secondary or more 82 16.7
Family income
≥ 3 MW 146 29.7












< 90 264 53.8
≥ 90 227 46.2
Sitting time per day
4 h or less 321 65.5





Hysterectomy before 40 years 44 9.4
Hysterectomy after 40 years 41 8.7
Weight (Kg) 491 68.32 ± 12.46
Height (m) 491 1.54 ± 0.06
BMI (Kg/m2) 491 28.96 ± 4.83
Waist circumference (cm) 491 95.12 ± 10.73
SMI (kg/m2) 491 6.78 ± 0.87
Grip Strength (Kgf) 491 25.86 ± 5.35
Knee Flexion Strength (Kgf) 491 14.90 ± 4.86
Knee Extension Strength (Kgf) 491 16.51 ± 4.18
Gait speed (m/s) 491 0.99 ± 0.18
Chair Stand (s) 491 10.20 ± 2.04
MW minimum wages, BMI body mass index, SMI skeletal muscle mass index
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greater total fat than New York dwelling Caucasians,
but researchers were unable to separate the ethnic
and socioeconomic influences [47].
Obesity is increasing in Brazilian female adolescents
and women without a marked socioeconomic gradient
[15]. The high prevalence of obesity in our study popula-
tion is in the range of what has been reported in the lit-
erature for adult women in Northeast Brazil [48–50].
Andrade et al. [51] found a similar prevalence of 55.5 %
(≥88 cm), based on waist circumference in women with
a mean age of 39.9 years [51].
Concerning sarcopenia, in a study conducted in
France, the prevalence was 9 % for individuals between
45 and 54 years, 13.5 % in the group aged between 55
and 64 years, and reaching 64.3 % in those aged 85 years
or older, with no difference between men and women,
indicating that sarcopenia is already present in middle-
aged populations. Sarcopenia was negatively associated
Table 2 Sample characteristics among obese, normal, sarcopenic and sarcopenic obese groups
Variables Obese Normal Sarcopenia Sarcopenic obesity p value
n = 331 (67.4 %) n = 64 (13.0 %) n = 61 (12.4 %) n = 35 (7.1 %)
n (%)
Age
≤ 45 years 67 (67.6 %) 10 (10.1 %) 14 (14.1 %) 8 (8.1 %) 0.88
46–49 years 96 (65.8 %) 24 (16.4 %) 17 (11.6 %) 9 (6.2 %)
50–54 years 109 (69.9 %) 19 (12.2 %) 19 (12.2 %) 9 (5.8 %)
>55 years 59 (65.6 %) 11 (12.2 %) 11 (12.2 %) 9 (10.0 %)
Education
Less than primary education 148 (72.2 %) 26 (12.7 %) 18 (8.8 %) 13 (6.3 %) 0.09
Between primary and secondary 135 (66.2 %) 25 (12.3 %) 26 (12.7 %) 18 (8.8 %)
Secondary or more 48 (58.5 %) 13 (15.9 %) 17 (20.7 %) 4 (4.9 %)
Family income
≥ 3 MW 97 (66.4 %) 23 (15.8 %) 19 (13.0 %) 7 (4.8 %) 0.41
< 3 MW 234 (67.8 %) 41 (11.9 %) 42 (12.2 %) 28 (8.1 %)
Common law
No 86 (61.9 %) 25 (18.0 %) 19 (13.7 %) 9 (6.5 %) 0.18
Yes 245 (69.6 %) 39 (11.1 %) 42 (11.9 %) 26 (7.4 %)
Race
White 129 (67.2 %) 25 (13.0 %) 24 (12.5 %) 14 (7.3 %) 0.26
Black 24 (88.9 %) 1 (3.7 %) 0 (0.0 %) 2 (7.4 %)
Pardo (Mixed race) 177 (65.6 %) 37 (13.7 %) 37 (13.7 %) 19 (7.0 %)
Physical activity
No 241 (66.9 %) 47 (13.1 %) 45 (12.5 %) 27 (7.5 %) 0.96
Yes 89 (68.5 %) 17 (13.1 %) 16 (12.3 %) 8 (6.2 %)
Walking (min/week)
<90 179 (67.8 %) 28 (10.6 %) 38 (14.4 %) 19 (7.2 %) 0.22
≥ 90 152 (67.0 %) 36 (15.9 %) 23 (10.1 %) 16 (7.0 %)
Sitting time per day
4 h or less 216 (67.3 %) 36 (11.2 %) 45 (14.0 %) 24 (7.5 %) 0.22
More than 4 h 114 (67.5 %) 28 (16.6 %) 16 (9.5 %) 11 (6.5 %)
Menopausal status
Premenopausal 58 (56.9 %) 18 (17.6 %) 14 (13.7 %) 12 (11.8 %) 0.05
Perimenopausal 113 (74.3 %) 14 (9.2 %) 19 (12.5 %) 6 (3.9 %)
Post-menopausal 91 (70.0 %) 15 (11.5 %) 18 (13.8 %) 6 (4.6 %)
Hysterectomy before 40 years 26 (59.1 %) 9 (20.5 %) 3 (6.8 %) 6 (13.6 %)
Hysterectomy after40 years 24 (58.5 %) 6 (14.6 %) 6 (14.6 %) 5 (12.2 %)
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with BMI, although the authors did not report on SO
[52].
Findings on grip strength
Low muscle mass predisposes physical function decline
and increases the risk of falls, disability, poor quality of
life and mortality [53, 54]. It has been suggested that SO
could exert a synergistic impact on physical performance
of the elderly [12].
In concordance with a recent Brazilian study of
older women, we found that SO is associated with re-
duced grip strength [1]. Two additional studies sup-
port our results. First, Lim et al. [55] found
significant difference between these four sarcopenic-
obesity groups in older Asian women from Singapore
and concluded that obesity coupled with sarcopenia
results in worsening of performance and strength
parameters, including grip strength [55]. Second,
Baumgartner et al. [56] observed the lowest grip
strength among sarcopenic obese men and women of
60 years and greater in a United States population,
corroborating our results [56].
Previous research indicates that obese people have
higher absolute muscle strength and a similar or higher
‘strength to muscle size ratio’ compared to their lean
counterparts [57]. However, the disabling effect of excess
fat mass may reduce motor performance of complex
motor tasks that require body mass support or
mobilization [57, 58]. Non-sarcopenic and sarcopenic
obese women may be considered an apparently
homogenous group of obese women; however, they have
very different physical performance because of their
muscle mass. We are in agreement with Newman et al.
[54], who highlighted the importance of detecting obese
Table 4 Mean levels (unadjusted and adjusted) of physical performance according to groups (obesity and sarcopenia)
Variables Obese Normal Sarcopenia Sarcopenic obesity
n = 331 (67.4 %) n = 64 (13.0 %) n = 61 (12.4 %) n = 35 (7.1 %)
Mean (95 % CI) p value
Grip Strength (Kgf)
Unadjusted 26.49 (25.91–27.07) 26.91 (25.40–28.40) 23.54 (22.61–24.47) 22.07 (20.66–23.47) <0.001b
Adjusteda 26.94 (26.26–27.62) 26.93 (25.64–28.22) 23.65 (22.33–24.97) 21.88 (20.18–23.58) <0.001
Knee Flexion Strength (Kgf)
Unadjusted 15.48 (14.94–16.02) 15.47 (14.33–16.60) 13.19 (12.16–14.22) 11.26 (9.97–12.55) <0.001b
Adjusteda 15.73 (15.08–16.39) 15.59 (14.35–16.83) 13.14 (11.89–14.39) 11.41 (9.73–13.08) <0.001
Knee Extension Strength (Kgf)
Unadjusted 17.06 (16.60–17.51) 16.80 (15.68–17.91) 14.70 (13.87–15.52) 13.91 (12.64–15.18) <0.001b
Adjusteda 17.57 (17.01–18.13) 16.98 (15.93–18.04) 14.81 (13.74–15.87) 14.16 (12.73–15.58) <0.001
Gait speed (m/s)
Unadjusted 0.99 (0.96–1.00) 1.00 (0.95–1.04) 0.99 (0.94–1.03) 0.94 (0.86–1.01) 0.50
Adjusteda 1.01 (0.99–1.03) 1.01 (0.96–1.06) 1.00 (0.96–1.05) 0.96 (0.90–1.02) 0.50
Chair Stand (s)
Unadjusted 10.29 (10.06–10.51) 9.79 (9.33–10.24) 9.71 (9.21–10.20) 11.00 (10.18–11.82) 0.009c
Adjusteda 10.11 (9.83–10.38) 9.71 (9.18–10.24) 9.76 (9.22–10.29) 10.89 (10.18–11.60) 0.03
aAdjusted for age, education and menopausal status. In multiple comparisons with Bonferroni corrections (p < 0.05)
bNormal ≠ sarcopenia and sarcopenic obesity; sarcopenia ≠ obese; obese ≠ sarcopenic obesity
cNormal ≠ sarcopenic obesity; sarcopenia ≠ sarcopenic obesity
Table 3 Quantitative variables of body composition according to the groups (obesity and sarcopenia)
Variables Obese Normal Sarcopenia Sarcopenic obesity p value
n = 331 (67.4 %) n = 64 (13.0 %) n = 61 (12.4 %) n = 35 (7.1 %)
mean ± SD mean ± SD mean ± SD mean ± SD
SMI (Kg/m2) 7.16 ± 0.69 6.60 ± 0.44 5.54 ± 0.41 5.66 ± 0.30 <0.001
BMI (Kg/m2) 31.14 ± 4.05 25.18 ± 2.06 22.58 ± 2.06 26.23 ± 2.68 <0.001
Waist circumference (cm) 100.25 ± 8.16 83.13 ± 5.88 80.98 ± 5.10 93.04 ± 3.34 <0.001
Waist-hip ratio 0.92 ± 0.05 0.84 ± 0.07 0.88 ± 0.04 0.91 ± 0.06 <0.001
SMI skeletal muscle mass index, BMI body mass index
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individuals who do not appear to be sarcopenic, but in
fact their muscle mass is reduced for their body size and
this reduction is masked by obesity [54].
Lower limb strength findings
We found lower limb strength differs between the
groups, with obese women showing similar results as
normal women, while sarcopenic obese women pre-
sented the worst performance. Miyatake et al. [59]
showed the absolute isometric strength of knee exten-
sors was higher in obese adults (20–60 years) compared
to non-obese controls [59]. Moreover, Rolland et al. [60]
showed that active obese elderly produced higher rela-
tive strength per unit muscle size than non-obese, while
sedentary obese older adults had similar muscle strength
compared to non-obese [60]. Consequently, favourable
adaptations to excess body mass on muscle function
might depend on the maintenance of sufficient physical
activity during aging. However in our study, the four
groups reported similar practice of regular physical ac-
tivity, sedentary and walking behaviours. The reason that
in our sample obese participants showed the same
strength as normal women might be due to the fact that
all have the same level of physical activity (Table 2).
Findings on chair stands
Unlike strength variables, obese and sarcopenic obese
women took longer time for chair stands compared
with normal and sarcopenic women. Chair stands is
an activity in which the body sequentially displaces it-
self in the shortest time possible and requires more
than strength; it also involves muscle power and co-
ordination [57, 58]. For chair stands, the SO women
performed even worse than the sarcopenic, which
corroborates reviewed studies stating that central fat
and relative loss of fat-free mass can determine the
health risk associated with obesity at older ages [61].
Sarcopenia and obesity may act synergistically, leading
to functional and metabolic changes [62], and our
results provide evidence for this synergism by show-
ing the decline in the chair standing performance in
SO participants. Waters et al. [63] found several
functional deficits in the SO group relative to normal,
sarcopenic and obese women, with the worst per-
formance on the chair stands test by SO. However,
Lim et al. [55] found no significant difference across
groups in this test, despite a longer observed time in
the SO group [55].
Gait speed findings
We did not find any significant differences in gait speed
across groups despite the fact that high intermuscular
fat in the thigh is a known predictor of gait-speed de-
cline [64]. Fat infiltration into muscle contributes to the
loss of mobility associated with aging, and decreasing
thigh muscle area is also predictive of decline in gait
speed [64].
The observed lowest mean values of gait speed in
women with SO, albeit non-significant, may reflect on
their functional capacity and quality of life in the near
future. While Meng et al. [10] found an absence of asso-
ciation between gait speed and the groups (obesity, sar-
copenia and SO) in older women [10], Lim et al. [55]
reported lower gait speed in sarcopenic obese older
Asian men and women (≥65 years) from Singapore [55].
Limitations and strengths
Our research has some limitations. The participants
were middle-aged women from Northeast Brazil, there-
fore caution should be used in inferring the results to
other populations. Firstly, cross cultural comparisons of
prevalence and distribution of SO are difficult due to
variability in body sizes and body composition, as well as
the lack of standard protocols in diagnosis of SO. This
diagnosis is usually based on combinations of body com-
position indices and muscle mass with varying popula-
tion specific cut-off points, as is usually recommended
to study of diverse populations [47]. Second, we used a
convenience sample and our participants might have
been healthier than the average target population. The
possibility of healthy volunteer bias cannot be ruled out.
However, education and income of the study sample is
similar to the census data for the women of similar ages
residing in the city of Parnamirim. Lastly, there is a pos-
sibility of information bias due to self-reported measures
of health behaviors; however, since there is no reason to
think that this bias is related to physical performance,
the misclassifications are probably non-differentiatial.
The main strength of this study is its focus on a very
rarely studied condition-sarcopenic obesity-in lower in-
come middle-aged women. Objective measurement of
physical performance and body composition by valid,
non-invasive, and inexpensive tools is another strength
of this study.
Relevant clinical implications
Obesity associated with sarcopenia seems to worsen
physical performance, beyond what has been reported
by obesity or sarcopenia alone. Although the differ-
ences between the groups were relatively small, it has
been shown in the literature that changes in chair
stand performance, for example, provide a marker of
current health and were predictive of mortality among
middle-aged women in a ten years period [65], and
also predictive of disability in older adults [23].
Investigation of sarcopenia and sarcopenic obesity
should be considered in the clinical assessment of meno-
pausal women. Furthermore, preventive measures and/
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or rehabilitation in relation to SO need to be imple-
mented to decrease the ill effects of SO.
Conclusion
Sarcopenic obesity was relatively frequent in middle-
aged women from Northeast Brazil, and it was associ-
ated with poor physical performance. Sarcopenic obesity
may occur in middle-aged women with subsequent per-
formance limitations beyond sarcopenia—related muscle
mass or obesity alone.
The number of obese women is rapidly increasing in
many Latin America countries and a substantial propor-
tion of middle-aged women may be affected both by
obesity and low muscle mass. It is anticipated that SO
will be a future public health burden.
Most studies on SO have been conducted in older
adults. Further research in the etiology and onset of SO
in middle-aged women is needed. These studies may in-
clude longitudinal data to confirm our cross-sectional
findings. Furthermore, an assessment of the efficacy of
interventions to maintain muscle mass and strength in
this age group should be carried out.
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